CNS Drugs (journal)
CNS Drugs is a peer-reviewed medical journal that publishes comprehensive reviews on all major therapeutic areas of neurological and psychiatric drug therapy. The journal was established in 1992 and is published by Adis International, a division of Springer Science+Business Media. The editor-in-chief is Suzanne M. Dufour.
Scope[edit | edit source]
The journal covers all aspects of the treatment of neurological and psychiatric disorders. Topics include pharmacology, clinical trials, drug interactions, pharmacoeconomics, and drug safety. The journal also publishes special reports, commentaries, and letters to the editor.
Abstracting and indexing[edit | edit source]
The journal is abstracted and indexed in PubMed, Scopus, EMBASE, Chemical Abstracts Service, and the Science Citation Index Expanded. According to the Journal Citation Reports, the journal has a 2019 impact factor of 4.803.
See also[edit | edit source]
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
